InspireMD (NSPR) Cash from Investing Activities (2010 - 2025)
InspireMD's (NSPR) quarterly Cash from Investing Activities came in at -$45.1 million in Q4 2025, down 647.62% year-on-year from $8.2 million in Q4 2024, and down 697.74% quarter-over-quarter from $7.6 million in Q3 2025.
InspireMD (NSPR) Cash from Investing Activities (2010 - 2025) Analysis & Trends
InspireMD's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$45.1 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 647.62% year-over-year to -$45.1 million in Q4 2025; TTM through Dec 2025 was -$30.6 million, a 341.75% decrease from a year earlier, with the FY2025 full-year figure at -$30.6 million, down 341.75% from the prior year.
- Cash from Investing Activities eased to -$45.1 million in Q4 2025 per NSPR's latest filing, from $7.6 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $8.2 million in Q4 2024 and bottomed at -$45.1 million in Q4 2025.
- The 5-year median for Cash from Investing Activities is $1.9 million (2021), against an average of -$2.4 million.
- Across the five-year window, Cash from Investing Activities slumped 49255.1% in 2021 and surged 22994.44% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at $1.8 million in 2021, then jumped by 111.08% to $3.9 million in 2022, then slumped by 100.93% to -$36000.0 in 2023, then jumped by 22994.44% to $8.2 million in 2024, then plunged by 647.62% to -$45.1 million in 2025.
- Per Business Quant, the three latest NSPR Cash from Investing Activities figures stand at -$45.1 million (Q4 2025), $7.6 million (Q3 2025), and $5.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.86 Bn | 176.56 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.65 Bn | 125.78 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.75 Bn | 99.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.34 Bn | 66.89 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.65 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 28.35 Bn | 26.07 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | -298.50 Mn |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -475.32 Mn |
| 10 | InspireMD | 42.52 Mn | -11.69 Mn | 1.18 Mn | -45.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -45.14 Mn |
| Dec 31, 2025 | -45.14 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Sep 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Jun 30, 2025 | 5.32 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Dec 31, 2024 | 8.24 Mn |
| Sep 30, 2024 | -5.92 Mn |
| Sep 30, 2024 | -5.92 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Jun 30, 2024 | 5.51 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Mar 31, 2024 | 4.82 Mn |
| Dec 31, 2023 | -36,000.00 |
| Dec 31, 2023 | -36,000.00 |
| Sep 30, 2023 | 6.39 Mn |
| Sep 30, 2023 | 6.39 Mn |